References
- Bauer KA, Rosendaal FR, Heit JA. Hypercoagulability: too many tests, too much conflicting data. Hematology Am Soc Hematol Educ Program 2002;1:353–68
- Kupferminc MJ. Thrombophilia and pregnancy. Reprod Biol Endocrinol 2003;1:111. https://doi.org/http://www.rbej.com/content/1/1/111
- Koneti RA, Kaplan R, Sheth S. Inherited thrombophilic states. Semin Thromb Hemost 1998;24:3–12
- Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999;353:1167–73
- Couto E, Nomura ML, Barini R, Silva JL. Pregnancy-associated venous thromboembolismin combined heterozygous factor V Leiden and prothrombin G20210A mutations. Sao Paulo Med J 2005;123:286–8
- Gerhardt A, Scharf RE, Beckmann MW, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000;342:374–80
- De Stefano V, Martinelli I, Mannucci PM, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med 1999;341:801–6
- Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb Haemost 2004;91:700–11
- Fiehen C, Derksen R, Grott PG, et al. Treatment of women with aPL in pregnancy. Ann Rheum Dis 2001;60:717–18
- Rand JH, Wu X-X, Andree HAM, et al. Pregnancy loss in the antiphospholipid-antibody syndrome – a possible thrombogenic mechanism. N Engl J Med 1997;337:154–60
- Bertina RM. Molecular risik factor for thrombosis. Thromb Haemost 1999;82:601–9
- Poul H. Thrombophilic conditions in the pathogenesis of venous thromboembolism. Vintr Lek 2006;52:17–25
- Pabinger I. Thrombophilia and its impact on pregnancy. Hamostaseologie 2008;28:130–4
- Salvagano GL, Lippi G, Franchini M, et al. The cost-benefit ratio of screening pregnantwomen for thrombophilia. Blood Transfus 2007;5:189–203
- Jadaon MM. Epidemiology of prothrombin G20210A mutation in the Mediterranean region. Mediterr J Hematol Infect Dis 2011;3:e2011054
- Mackhwort-Young CG. Antiphospholipid syndrome: multiple mechanisms. Clin Exp Immunol 2004;136:393–401
- Mackill LH, Germain SJ, Nelson-Piercy C. Pregnancy plus: systemic lupus erythematosus. BMJ 2007;335:933–6
- Jacobsen AF, Dahm A, Bergrem A, et al. Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms. J Thromb Haemost 2010;8:2443–9
- Cordoba I, Pegenaute C, González-López TJ, et al. Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation. Eur J Haematol 2012;89:250–5
- Preston FE, Rosendaal FR, Walker ID, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913–16
- Bucciarelli P, Passamonti SM, Biguzzi E, et al. Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism. J Thromb Haemost 2012;10:1783–91
- Korteweg FJ, Folkeringa N, Brouwer JL, et al. Fetal loss in women with hereditary thrombophilic defects and concomitance of other thrombophilic defects: a retrospective family study. BJOG 2012;119:422–30
- De Vries JI, Dekker GA, Huijgens PC, et al. Hyperhomocysteinemia and protein S deficiency in complicated pregnancies. BJOG 1997;104:1248–54
- Infante-Rivard C, Weinberg CR. Parent-of-origin transmission of thrombophilic alleles to intrauterine growth-restricted newborns and transmission-ratio distortion in unaffected newborns. Am J Epidemiol 2005;162:891–7
- Jackson J, Wailoo M, Thompson J, Petersen S. Early physiological development of infants with intrauterine growth retardation. Arch Dis Child Fetal Neonatal Ed 2004;89:46–50
- Kahn SR, Platt R, McNamara H, et al. Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia Study. Am J Obstet Gynecol 2009;200:151.e1–9
- Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2005;132:171–96
- Currie L, Peek M, McNiven M, et al. Is there an increased maternal-infant prevalence of Factor V Leiden in association with severe pre-eclampsia? BJOG 2002;109:191–6
- Facchinetti F, Marozio L, Grandone E, et al. Thrombophilic mutations are a main risk factor for placental abruption. Haematologica 2003;88:785–8
- Alijotas RJ, Casellas CM, Ferrer OR, et al. Are anti-beta-glycoprotein-1 antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women? Am J Reprod Immunol 2008;60:229–37